<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCD</journal-id><journal-title-group><journal-title>World Journal of Cardiovascular Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-5329</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/wjcd.2023.133009</article-id><article-id pub-id-type="publisher-id">WJCD-123994</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Acute Coronary Syndromes: Epidemiological, Clinical and Management Aspects in Thies (Senegal)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Désiré</surname><given-names>Alain Affangla</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean-Paul</surname><given-names>Degue</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wally</surname><given-names>Niang Mboup</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Stéphanie</surname><given-names>Claudia Akanni</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sheikh</surname><given-names>Mouhamadou B. M. Diop</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Malick</surname><given-names>Ndiaye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean-Michel</surname><given-names>Amath Dione</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hugues</surname><given-names>Elie Elame Ngwa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adamson</surname><given-names>Phiri</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djibril</surname><given-names>Marie Ba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohamed</surname><given-names>M. C. B. O. Leye</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Health Sciences Training and Research Unit, University of Thies, Thies, Senegal</addr-line></aff><aff id="aff1"><addr-line>Cardiac Unit, Saint Jean de Dieu Hospital, Thies, Senegal</addr-line></aff><pub-date pub-type="epub"><day>17</day><month>03</month><year>2023</year></pub-date><volume>13</volume><issue>03</issue><fpage>114</fpage><lpage>123</lpage><history><date date-type="received"><day>16,</day>	<month>January</month>	<year>2023</year></date><date date-type="rev-recd"><day>27,</day>	<month>March</month>	<year>2023</year>	</date><date date-type="accepted"><day>30,</day>	<month>March</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Purpose:
   To describe the epidemiological, clinical and management characteristics of acute coronary syndromes (ACS) in Thies, Senegal. <b>Methods:</b> This was a prospective study that included consecutively from October 1<sup>st</sup>, 2018 to March 03<sup>rd</sup>, 2019, patients aged 18 years or older admitted for an ACS at the DIABCARMET department of the Saint Jean de Dieu Hospital in Thies. <b>Results:</b> Of the 516 patients admitted, 29 had ACS, the prevalence was 5.62%. The average age of the patients was 64.2 &#177; 11.6 years. Nineteen patients (65.5%) were male and 10 (34.5%) were female, the sex ratio was 1.91. The number of direct admissions was 18 (62%) versus 11 patients (38%) referred. The mode of transport was a private vehicle in 19 patients (65.5%), an ambulance in 7 patients (24.1%) and public transport in 3 patients (10.3%). STEMI (ST segment elevation myocardial infarction) was the most common presentation observed in 19 patients (65.5%). Fifteen patients (51.7%) were admitted before the 12<sup>th</sup> hour. Of the 19 patients with STEMI, 11 (57.9%) had arrived in hospital before the 12<sup>th</sup> hour and 10 patients had streptokinase thrombolysis. No patients received primary PCI. Ten patients (34.5%) had heart failure and five patients (17.2%) died during hospitalization. <b>Conclusion:</b> Delayed consultation and high mortality characterize ACS in Thies. Prevention must be the rule.
 
</p></abstract><kwd-group><kwd>ACS</kwd><kwd> Myocardial Infarction</kwd><kwd> Thrombolysis</kwd><kwd> Thies</kwd><kwd> Senegal</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>In recent years, many developing countries, and particularly those in sub-Saharan Africa (SSA), have experienced a sharp increase in acute coronary syndrome (ACS) in a context of rapid urbanization, changes in lifestyle and diet, an aging population and, above all, uncontrolled cardiovascular risk factors [<xref ref-type="bibr" rid="scirp.123994-ref1">1</xref>]. Coronary heart disease (CHD) is now 1 of the 3 leading causes of death in most SSA countries increasing the burden of health expenditures in regions that are also struggling with uncontrolled infectious diseases and malnutrition [<xref ref-type="bibr" rid="scirp.123994-ref2">2</xref>].</p><p>The multicentre sub-Saharan CORONAFRIC survey reveals an increase in the prevalence of coronary artery disease in Dakar [<xref ref-type="bibr" rid="scirp.123994-ref3">3</xref>]. The acute form of coronary artery disease is Acute Coronary Syndrome (ACS), an emergency whose prognosis is highly dependent on the time taken to manage [<xref ref-type="bibr" rid="scirp.123994-ref4">4</xref>]. We report on our experience in managing the ACS in Thies, Senegal.</p></sec><sec id="s2"><title>2. Methods</title><p>This was a cross-sectional, prospective study with consecutive recruitment of hospitalized patients for ACS in the department for the management of diabetes and cardiometabolic diseases DIABCARMET of the Saint Jean de Dieu hospital of Thies during the period from October 1<sup>st</sup>, 2018 to March 03<sup>rd</sup>, 2019.</p><p>All patients with angina at rest and/or significant electrocardiographic changes to the ST segment (elevation or depression), or symmetric negative T-waves were included. And we excluded patients with stable angina, chest pain, with non-specific electrocardiographic changes, old myocardial infarction.</p><p>The parameters studied were:</p><p>&#173; The consultation time: time between the beginning of the symptomatology and the patient’s arrival at the hospital;</p><p>&#173; Description of the symptoms;</p><p>&#173; The mode of transport used by the patient to get to the hospital: private vehicle, hospital ambulance, ambulance, public transport (taxi and bus), others;</p><p>&#173; Management time: time between patient arrival and completion of ECG and anti-thrombotic and/or fibrinolytic treatment;</p><p>&#173; The characteristics of the electrocardiogram (ECG): the persistent ST segment elevation or the ST-segment depression, the territory concerned;</p><p>&#173; Socio-demographic data: age in years by date of birth on the national identity card; the socio-economic level according to the World Bank’s 2013 poverty index for every person living on less than $1.25 (700 CFA) per day in developing countries [<xref ref-type="bibr" rid="scirp.123994-ref5">5</xref>] ;</p><p>&#173; The cardiovascular risk factors: physical inactivity defined by physical activity less than 120 minutes per week [<xref ref-type="bibr" rid="scirp.123994-ref6">6</xref>] ; smoking; obesity defined by BMI &gt; 30 kg/m<sup>2</sup> and/or waist circumference &gt; 102 cm in men and &gt;88 cm in women [<xref ref-type="bibr" rid="scirp.123994-ref7">7</xref>] ; hypertension retained before taking anti-hypertensive medication and/or arterial pressure ≥ 180/110 mm Hg and/or arterial pressure ≥ 140/90 mm Hg controlled at least twice outside of an episode of pain [<xref ref-type="bibr" rid="scirp.123994-ref8">8</xref>] ; diabetes retained by taking diabetes medication and/or fasting glucose ≥ 1.26 g/L twice [<xref ref-type="bibr" rid="scirp.123994-ref9">9</xref>] ; dyslipidemia with HDL-cholesterolemia &lt; 0.40 g/l in men and &lt; 0.50 g/l in women and/or total cholesterolemia &gt; 2 g/l and/or LDL-cholesterolemia &gt; 1.6 g/l [<xref ref-type="bibr" rid="scirp.123994-ref10">10</xref>] ;</p><p>&#173; Assessment of left ventricular systolic function by measurement of ejection fraction (LVEF) at echocardiography; systolic dysfunction corresponding to LVEF &lt; 50% [<xref ref-type="bibr" rid="scirp.123994-ref11">11</xref>] ;</p><p>&#173; The treatment administered, in this case the fibrinolytic used;</p><p>&#173; The intra-hospital evolution: the efficiency of thrombolysis appreciated by the decrease of more than 50% of the ST segment elevation, the Killip classification of heart failure, mortality [<xref ref-type="bibr" rid="scirp.123994-ref4">4</xref>].</p><p>The data were collected and analyzed with the statistical tools of the software Epi info version 3.5.4 of 30 July 2012, CDC, Atlanta (USA). The Khi-square test was used for the comparison of proportions and the variant analysis test (ANOVA) or the non-parametric Kruskall-Walis test, depending on whether the mean variances were homogeneous or not, for the comparison of a quantitative variable to a qualitative group variable. The significance threshold was set to p ≤ 0.05.</p></sec><sec id="s3"><title>3. Results</title><p>During the study period, 29 patients had an ACS in 516 hospitalized patients; the prevalence was 5.62%. Patients with STEMI were 19 (65.5%) and those with non-STEMI were 10 (34.5%) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>These were 19 men (65.5%) and 10 women (34.5%), a sex ratio of 1.9. The average age of patients was 64.2 &#177; 11.6 years (extremes of 45 and 98 years) and the 55 - 64 age group was the most represented (n = 12; 41.3%). Among men, the average age was 63.3 years &#177; 9 years (extremes of 51 and 80 years) and among women 66 years &#177; 15.8 years (extremes of 45 and 98 years). Majority of patients (n = 23; 79.31%) resided in the city of Thies. Twelve patients (41.4%) lived below the poverty line compared to 17 (58.6%) who lived above it. Almost half of patients 13 (44.8%) were out of school. The number of patients enrolled was 16 (55.2%) of whom 5 (17.2%) were primary, 2 (6.9%) secondary and 9 (31%) university students.</p><p>A patient (3.4%) had a notion of early coronary disease in one of his parents. Other cardiovascular risk factors found were: physical inactivity (n = 28; 96.5%),</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of acute coronary syndromes</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Acute Coronary Syndromes</th><th align="center" valign="middle" >Number (n)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >STEMI</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >65.5</td></tr><tr><td align="center" valign="middle" >NON-STEMI</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >34.5</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p>age (n = 26; 89.6%), hypertension (n = 20; 69%), diabetes (n = 12; 41.3%), dyslipidemia (n = 10; 34.5%), smoking (n = 10; 34.5%), obesity (n = 2; 6.9%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The number of risk factors averaged 3.72 &#177; 1 risk factor per patient (extremes of 2 and 6 risk factors) (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Patients admitted directly were 18 (62%) compared to 11 (38%) referred. Private vehicles were the most used means of transport, found in 19 patients (65.5%) while 7 patients (24.1%) were transported by ambulance and 3 patients (10.3%) by taxi (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>). The average intake time from the onset of pain was 31 &#177; 34.7 hours (extremes of 02 hours and 96 hours). It was 20.9 &#177; 24 hours in patients with STEMI and 46.9 &#177; 43.8 hours in patients with non-STEMI. Among patients admitted before the 12<sup>th</sup> hour, 11 (37.9%) had a STEMI.</p><p>All patients (n = 29; 100%) had angina at rest. This pain was typical retrosternal chest in 21 patients (72.4%) and atypical in 8 patients (27.6%) of which 6 (20.7%) epigastralgia type. Only one patient (3.4%) had prior knowledge of the symptoms of coronary artery disease.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of cardiovascular risk factors in patients with ACS</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Number of cardiovascular risk factors</th><th align="center" valign="middle" >Number (n)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >10.34</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >31.03</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >37.93</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >17.24</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.45</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p>Nineteen patients (65.51%) were in Killip stage I with no signs of heart failure, while 10 (34.49%) had signs of heart failure, including 3 patients (10.3%) in Killip stage II, 4 in stage 3 (13.8%) and 3 patients in stage 4 (10.3%) (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>At electrocardiogram, the most concerned location were anteroseptal apical (n = 10; 34.5%), inferior (n = 8; 27.6%) and anteroseptal (n = 4; 13.79%) (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p>Twenty-five patients had received echocardiography and LV systolic dysfunction was observed in 13 patients (52%) with an average LVEF was 51.2% &#177; 13% (extremes 22% and 68%).</p><p>Of the 19 patients (65.5%) with STEMI, 11 (57.9%) arrived before the 12<sup>th</sup> hour and 8 (42.1%) after the 12<sup>th</sup> hour. The average time between onset of pain and initiation of treatment was 31.3 &#177; 30 hours (extremes of 3 hours and 96 hours). This average treatment time was 5.6 &#177; 3.1 hours in patients arriving before the 12<sup>th</sup> hour. Of the 11 patients with STEMI, 10 (90.9%) had received fibrinolytic treatment. Streptokinase was used in all patients (n = 10; 100%). One patient (9.1%) among the 11 did not receive fibrinolytic treatment due to persistent severe hypertension. The significant decrease in the ST segment was however observed in only 2 of the 10 thrombolysed patients (20%).</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Treatment time from onset of pain</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Delay</th><th align="center" valign="middle" >Headcount (n)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Before the 6<sup>th</sup> Hour</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >34.5</td></tr><tr><td align="center" valign="middle" >6 - 12<sup>th</sup> Hour</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >17.2</td></tr><tr><td align="center" valign="middle" >12 - 24<sup>th</sup> Hour</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >13.8</td></tr><tr><td align="center" valign="middle" >More than 24 Hours</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >34.5</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Electrocardiogram location of the myocardial injury</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Location</th><th align="center" valign="middle" >Headcount (n)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Posteroseptal</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.4%</td></tr><tr><td align="center" valign="middle" >Anteroseptal</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >13.8%</td></tr><tr><td align="center" valign="middle" >Anteroseptal-apical</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >34.5%</td></tr><tr><td align="center" valign="middle" >inferior</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >27.6%</td></tr><tr><td align="center" valign="middle" >Circumferential</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.9%</td></tr><tr><td align="center" valign="middle" >Lateral</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.9%</td></tr><tr><td align="center" valign="middle" >Apical</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.9%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><p>Thrombolysis had to be stopped in 1 patient (3.4%) who had anaphylactic shock, 1 patient (3.4%) had hemorrhage. Five patients died during hospitalization: a mortality of (17.2%) including 4 patients (21%) with STEMI and 1 patient (10%) with non-STEMI. A patient was transferred to another centre. The average length of hospitalization was 5.6 &#177; 2 days (extremes of 1 day and 8 days).</p></sec><sec id="s4"><title>4. Discussion</title><p>The prevalence of 5.62% of ACS in our study was higher than that found by Mboup et al. in Dakar in 2014 [<xref ref-type="bibr" rid="scirp.123994-ref12">12</xref>] and by Pessinaba et al. in Lom&#233; in 2018 [<xref ref-type="bibr" rid="scirp.123994-ref13">13</xref>] which were 4.05% and 3.5% respectively. In contrast, N’guetta et al. in Abidjan [<xref ref-type="bibr" rid="scirp.123994-ref14">14</xref>] found a higher prevalence of 13.5% that could be explained by the fact that this was work done in an angioplasty reference centre. The increase in the prevalence of coronary artery disease in African countries south of the Sahara was highlighted by the multicentre study CORONAFRIC II [<xref ref-type="bibr" rid="scirp.123994-ref3">3</xref>] with a hospital prevalence that had increased from 3.17% in 1991 to 4.05% in Dakar. This increase in the prevalence of coronary heart disease may be due to increasing urbanization and changes in the way of life of populations.</p><p>The patients in our work, whose average age was 64, were older than those in the African series. Indeed, Mboup et al. in Dakar [<xref ref-type="bibr" rid="scirp.123994-ref12">12</xref>], Nguetta et al. in Abidjan [<xref ref-type="bibr" rid="scirp.123994-ref14">14</xref>] and Yam&#233;ogo et al. in Ouagadougou [<xref ref-type="bibr" rid="scirp.123994-ref15">15</xref>] recovered an average age of 57.1 years, 55 years and 56 years respectively. On the other hand, the patients in our work were slightly younger than in the western series especially in France where he was 66 years old [<xref ref-type="bibr" rid="scirp.123994-ref16">16</xref>]. The prevalence of coronary artery disease increases with age and improved life expectancy of populations. Similarly, the higher prevalence of ACS in males and their younger age found in our work corroborate the literature [<xref ref-type="bibr" rid="scirp.123994-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref13">13</xref>].</p><p>Ninety-one percent (91%) of the patients in our study had at least two cardiovascular risk factors as found in the early [<xref ref-type="bibr" rid="scirp.123994-ref17">17</xref>] and recent work in Senegal [<xref ref-type="bibr" rid="scirp.123994-ref12">12</xref>]. The main risk factors in our work were, in order of frequency, physical inactivity, age, and hypertension as found in the INTERHEART study [<xref ref-type="bibr" rid="scirp.123994-ref18">18</xref>]. All our patients had at least 2 cardiovascular risk factors. These results are also comparable to the results of the CORONAFRIC [<xref ref-type="bibr" rid="scirp.123994-ref3">3</xref>] survey and the work of Mboup et al. [<xref ref-type="bibr" rid="scirp.123994-ref12">12</xref>]. In work at the same centre as this study in 2016, Affangla et al. found at least 3 other risk factors in 85.86% of hypertensive patients [<xref ref-type="bibr" rid="scirp.123994-ref19">19</xref>].</p><p>The average intake time in our study was 31 34.7 hours. Mboup and Nguetta [<xref ref-type="bibr" rid="scirp.123994-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref14">14</xref>] had a later admission period of 53.2 &#177; 21.3 hours and 44.7 &#177; 47.9 hours respectively. One patient in two in our work (n = 15; 51.7%) was admitted before the 12<sup>th</sup> hour. Ngaide [<xref ref-type="bibr" rid="scirp.123994-ref20">20</xref>] and Mboup [<xref ref-type="bibr" rid="scirp.123994-ref12">12</xref>] had a lower consultation rate before the 12<sup>th</sup> hour, of 42% and 37.9% respectively.</p><p>In our work the direct admission rate of 62% was comparable to that found by Mboup et al. in Dakar (57%) but higher than that reported by Ngaid&#233; and Nguetta, which were respectively 45.5% and 30% [<xref ref-type="bibr" rid="scirp.123994-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref20">20</xref>]. The high rate of direct admission high in our work could be explained by the fact that the DIABCARMET center of the Saint Jean de Dieu Hospital is the only cardiology service in the region of Thies practicing thrombolysis in the management of STEMI.</p><p>The private vehicle was the most common mode of transportation in our work (n = 19; 65.5%) as in all sub-Saharan works [<xref ref-type="bibr" rid="scirp.123994-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref15">15</xref>]. The preferred mode of transportation for a patient with ACS is the ambulance. The significant disparity with the practices observed in Tunisia and Europe [<xref ref-type="bibr" rid="scirp.123994-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref22">22</xref>] could be explained by the low socio-economic level of the populations of sub-Saharan Africa and the lack of an organised ACS management system [<xref ref-type="bibr" rid="scirp.123994-ref15">15</xref>].</p><p>Clinically, pain was the main symptom as found in the literature [<xref ref-type="bibr" rid="scirp.123994-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref18">18</xref>]. It is present in all patients (100%) of our study, as in the series of Pessinaba [<xref ref-type="bibr" rid="scirp.123994-ref13">13</xref>] and Yam&#233;ogo [<xref ref-type="bibr" rid="scirp.123994-ref15">15</xref>] while Mboup finds it in 96.6% of patients. Epigastralgia were found in our study (20.7%). Hakim found similar results (19%) [<xref ref-type="bibr" rid="scirp.123994-ref18">18</xref>]. The frequency of epigastric localization of pain in ACS highlights the relevance of performing an ECG in front of acute epigastric pain. In our study, reaching the previous territory was the most common (48.3%), followed by reaching the lower territory (27.6%). The predominant anterior location of the ACS is found in all work [<xref ref-type="bibr" rid="scirp.123994-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref16">16</xref>]. Like Pessinaba et al. [<xref ref-type="bibr" rid="scirp.123994-ref13">13</xref>], we found no cases of right ventricular extension in contrast to Mboup and Ngaide, which were found in 13.6% and 16% of patients [<xref ref-type="bibr" rid="scirp.123994-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref20">20</xref>]. The prevalence of heart failure in our work (n = 10; 34.5%) was higher than the Mboup [<xref ref-type="bibr" rid="scirp.123994-ref12">12</xref>] and Nguetta [<xref ref-type="bibr" rid="scirp.123994-ref14">14</xref>] series, which had a prevalence of 16.9% and 27.8% and lower respectively than the Pessinaba [<xref ref-type="bibr" rid="scirp.123994-ref13">13</xref>] series, which had a heart failure prevalence of 50%. One in two patients (52%) in our work had LV systolic dysfunction in echocardiography. Heart failure secondary to left ventricular systolic dysfunction, a consequence of sudden coronary occlusion, is potentially reversible during ACS justifying early revascularization strategies. It is clearly established that thrombolysis significantly reduces complications and mortality in patients with ACS [<xref ref-type="bibr" rid="scirp.123994-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref15">15</xref>].</p><p>The rate of consultation before the 12<sup>th</sup> hour in patients with STEMI was 57.9% in our work and only 9.3% in the work of Yam&#233;ogo et al. in Ouagadougou [<xref ref-type="bibr" rid="scirp.123994-ref15">15</xref>]. The average treatment time compared to the onset of pain was 5.6 3.1 hours in our work compared to 3.4 1 hour in the work of Mboup et al. in Dakar [<xref ref-type="bibr" rid="scirp.123994-ref12">12</xref>]. There is then a great disparity in the time frames for consultation and management of the ACS in sub-Saharan countries, which would be linked to differences in the organization of health structures and the insufficient information of populations. Only one patient in our work (3.44%) had knowledge of the symptoms of ACS.</p><p>Streptokinase was the only fibrinolytic used in our study (100%) as in the Pessinaba, Yameogo and Ngaidae series [<xref ref-type="bibr" rid="scirp.123994-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref20">20</xref>]. This exclusive use of streptokinase can be explained by its low cost and availability compared to other fibrinolytics which are more used in the Western series and in the work of N’Guetta (8.2%).</p><p>The success rate of thrombolysis in our work was 20% much lower than the 59.02% found by Nga&#239;d&#233; in Dakar and Bohajja in Tunisia [<xref ref-type="bibr" rid="scirp.123994-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.123994-ref21">21</xref>]. We recorded a mortality rate of 9.68% close to that of Ngetta but lower than the mortality of 18% recovered by Mboup and 11% by Yam&#233;ogo and higher than the mortality of 6% recovered by Nga&#239;d&#233; [<xref ref-type="bibr" rid="scirp.123994-ref20">20</xref>].</p></sec><sec id="s5"><title>5. Conclusion</title><p>Acute coronary syndromes were common in Thies. The diagnosis was often late. The management was medical with still high mortality. The organization of a management system and prevention must be the priority.</p></sec><sec id="s6"><title>6. Limitation of the Study</title><p>Low patient numbers; unavailability of new generation fibrinolytics; very poor patient access to coronary angiography.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare that they have no conflict of interest in relation to this work.</p></sec><sec id="s8"><title>Cite this paper</title><p>Affangla, D.A., Degue, J.-P., Mboup, W.N., Akanni, S.C., Diop, S.M.B.M., Ndiaye, M., Dione, J.-M.A., Ngwa, H.E.E., Phiri, A., Ba, D.M. and Leye, M.M.C.B.O. (2023) Acute Coronary Syndromes: Epidemiological, Clinical and Management Aspects in Thies (Senegal). World Journal of Cardiovascular Diseases, 13, 114-123. https://doi.org/10.4236/wjcd.2023.133009</p></sec></body><back><ref-list><title>References</title><ref id="scirp.123994-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Yuyun, M.F., Sliwa, K., Kengne, A.P., et al. (2020) Cardiovascular Diseases in Sub- Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective. Global Heart, 15, 15. https://doi.org/10.5334/gh.403</mixed-citation></ref><ref id="scirp.123994-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2020) The Top 10 Causes of Death.  
https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death</mixed-citation></ref><ref id="scirp.123994-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Kassé, M. (2016) La maladie coronaire en Afrique: Résultats de l’enquête multicentrique CORONAFRIC II réalisée dans 11 pays de l’Afrique Sub saharienne. Thèse Médecine Université Cheikh Anta Diop de Dakar, Dakar, N°165.</mixed-citation></ref><ref id="scirp.123994-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ibanez, B., James, S., Agewal, J., et al. (2018) ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation. The Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC). European Heart Journal, 39, 119-177. https://doi.org/10.1093/eurheartj/ehx393</mixed-citation></ref><ref id="scirp.123994-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Ministère de l’Economie et des Finances (2012) Rapport de Suivi des OMD SEN 2000-2012.  
https://planipolis.iiep.unesco.org/en/2012/rapport-de-suivi-des-omd-2000-2012-6336</mixed-citation></ref><ref id="scirp.123994-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Appel, L.J., Brands, M.W., Daniels, S.R., et al. (2006) Dietary Approaches to Prevent and Treat Hypertension. A Scientific Statement from the AHA. Hypertension, 47, 296-308. https://doi.org/10.1161/01.HYP.0000202568.01167.B6</mixed-citation></ref><ref id="scirp.123994-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Consultation OMS sur l’obésité (2003) Obésité: Prévention et prise en charge de l’épidémie mondiale: Rapport d’une consultation de l’OMS. OMS, Genève, Série de rapports techniques, 894.  
http://apps.who.int/iris/bitstream/10665/42734/1/WHO_TRS_894_fre.pdf</mixed-citation></ref><ref id="scirp.123994-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Blacher, J., Halimi, J.M., Hanon, O., et al. (2013) Prise en charge de l’hypertension artérielle de l’adulte. Recommandations 2013 de la Société francaise d’hypertension artérielle. Annales de Cardiologie et d’Angéiologie, 62, 132-138.  
https://doi.org/10.1016/j.ancard.2013.04.009</mixed-citation></ref><ref id="scirp.123994-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Alberti, K.G. and Zimmet, P.Z. (1998) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus Provisional Report of a WHO Consultation. Diabetic Medicine, 15, 539-553.  
https://doi.org/10.1002/(SICI)1096-9136(199807)15:7&lt;539::AID-DIA668&gt;3.0.CO;2-S</mixed-citation></ref><ref id="scirp.123994-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Attias, D., Besse, B. and Lelouche, N. (2013-2014) Prise en charge des dyslipidémies. In: Cardiologie vasculaire, éditions Vernazorbes-Grego, Paris, 19-28.</mixed-citation></ref><ref id="scirp.123994-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Ponikowski, P., Voors, A., Anker, S., et al. (2016) 2016 ESC Guidelines for Heart Failure. European Heart Journal, 37, 2129-2200.  
https://doi.org/10.1093/eurheartj/ehw128</mixed-citation></ref><ref id="scirp.123994-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Mboup, M.C., Diao, M., Dia, K. and Fall, P.D. (2014) Les syndromes coronaires aigus à Dakar: Aspects cliniques thérapeutiques et évolutifs. The Pan African Medical Journal, 19, 126. https://doi.org/10.11604/pamj.2014.19.126.3155</mixed-citation></ref><ref id="scirp.123994-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Pessinaba, S., Baragou, S., et al. (2016) Les syndromes coronaires aigus: Aspects épidémiologiques, cliniques, paracliniques et thérapeutiques au CHU Campus de Lomé, Togo. Médecine et Santé Tropicales, 28, 285-288.</mixed-citation></ref><ref id="scirp.123994-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">N’Guetta, R., Yao, H., Ekou, A., et al. (2016) Prévalence et caractéristiques des syn- dromes coronariens aigus dans une population d’Afrique subsaharienne. Annales de Cardiologie et d’Angéiologie, 65, 59-63.  
https://doi.org/10.1016/j.ancard.2016.01.001</mixed-citation></ref><ref id="scirp.123994-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Yameogo, N.V., Samadoulougou, A., Millogo, G., et al. (2012) Délais de la prise en charge des syndromes coronariens aigus avec sus décalage du segment ST à Ouagadougou et facteurs associés à un allongement de ces délais: étude transversale à propos de 43 cas colligés au CHU-Yalgado de Ouagadougou. The Pan African Medical Journal, 13, 90. https://doi.org/10.11604/pamj.2012.13.90.1368</mixed-citation></ref><ref id="scirp.123994-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Hanssen, M., Cottin, Y., Khalife, K., et al. (2012) French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction. FAST-MI 2010. Heart, 98, 699-705.  
https://doi.org/10.1136/heartjnl-2012-301700</mixed-citation></ref><ref id="scirp.123994-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Koate, P., Diouf, S., Sylla, M., et al. (1981) Cardiopathies ischémiques à facteurs de risques cardio-vasculaires multiples chez le Sénégalais. Dakar Medical, 26, 377-387.</mixed-citation></ref><ref id="scirp.123994-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Steyn, K., Sliwa, K., Hawken, S., et al. (2005) Risk Factors Associated with Myocardial Infarction in Africa: The Interheart Africa Study. Circulation, 112, 3554-3561.  
https://doi.org/10.1161/CIRCULATIONAHA.105.563452</mixed-citation></ref><ref id="scirp.123994-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Affangla, D.A., Gueye, C., Simo Wabo, A., et al. (2016) Profil du risque cardio- vasculaire du patient hypertendu en consultation externe au centre de prise en charge du diabète et des maladies cardiométaboliques de l’hopital Saint Jean de Dieu de Thiès. Cardiologie Tropicale, 146, 15-20.</mixed-citation></ref><ref id="scirp.123994-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Ngaidé, A.A., Moctar, M.A., Sow, M., et al. (2019) Evaluation de la reperfusion myocardique par la thrombolyse intraveineuse dans les syndromes coronariens aigus avec sus décalage persistant du segment ST (SCA ST+).  
http://tropical-cardiology.com/Accueil/index.php/fr/2013-08-10-06-44-55/n-156-avr-mai-juin-2019/367</mixed-citation></ref><ref id="scirp.123994-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Bouhajja, B., Souissi, B., Ghazali, H., et al. (2014) Evaluation de la fibrinolyse par la streptokinase dans l’infarctus du myocarde avec sus décalage du segment ST admis aux urgences. La Tunisie Médicale, 92, 147-153.</mixed-citation></ref><ref id="scirp.123994-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Pistavos, C., Panagiotakos, D., Antonoulas, A., et al. (2005) Epidemiology of Acute Coronary Syndromes in a Mediterranean Country, Aims, Design and Baseline Characteristics of the Greek Study of Acute Coronary Syndrome (GREECS). BMC Public Health, 5, Article No. 23. https://doi.org/10.1186/1471-2458-5-23</mixed-citation></ref></ref-list></back></article>